Intensity Therapeutics Overview

  • Founded
  • 2012
Founded
  • Status
  • IPO Registration
  • Employees
  • 13
Employees
  • Latest Deal Type
  • IPO
  • (Announced)
  • Financing Rounds
  • 6

Intensity Therapeutics General Information

Description

Operator of a clinical-stage biotechnology company intended to offer cell-activating cancer treatments. The company offers situ vaccination and products capable of killing a tumor in a manner that allows for the adaptive immune system to recognize cancer and attack tumors with minimal side effects, providing doctors with safer and more efficacious chemotherapy treatments for refractory solid tumor cancers.

Contact Information

Ownership Status
In IPO Registration
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 61 Wilton Road
  • 3rd Floor
  • Westport, CT 06880
  • United States
+1 (203) 000-0000

Intensity Therapeutics Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Intensity Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Intensity Therapeutics‘s full profile, request access.

Request a free trial

Intensity Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a clinical-stage biotechnology company intended to offer cell-activating cancer treatments. The company offe
Biotechnology
Westport, CT
13 As of 2021
000.00
0000 0000-00-00
00000000 000.00

00000000

ure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur
0000 000000000
Rockville, MD
0 As of 0000
000.00
0000000000 0 000.00

00 00000

rehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat c
0000 000000000
Copenhagen N, Denmark
00 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Intensity Therapeutics Competitors (64)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CytImmune Sciences Venture Capital-Backed Rockville, MD 0 000.00 0000000000 0 000.00
00 0000000 Venture Capital-Backed Copenhagen N, Denmark 00 00000 00000000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
00000000 000000000 Formerly VC-backed Roseville, MN 00 000.00 000000&0 000.00
0000000 Corporation London, Canada 00 000.00 00000000 000.00
You’re viewing 5 of 64 competitors. Get the full list »

Intensity Therapeutics Patents

Intensity Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2897620-B1 Method of treating cancer Active 21-Sep-2012 000000000
AU-2017202970-B2 Method of treating cancer Active 21-Sep-2012 000000000 0
JP-2018123137-A Method of treating cancer Pending 21-Sep-2012 000000000 0
AU-2017202970-A1 Method of treating cancer Granted 21-Sep-2012 000000000
JP-2015533809-A How to treat cancer Granted 21-Sep-2012 A61K47/14 0

Intensity Therapeutics Executive Team (5)

Name Title Board Seat Contact Info
Lewis Bender Founder, Chief Executive Officer, President & Board Member
John Wesolowski Controller
Gregory Wade Ph.D Chief Financial Officer
Ian Walters MD Chief Medical Officer
You’re viewing 4 of 5 executive team members. Get the full list »

Intensity Therapeutics Board Members (4)

Name Representing Role Since
000000 000000 00 Self Board Member 000 0000
0000 00000 00.0 Self Board Member 000 0000
0000 00000000 00 Self Board Member 000 0000
You’re viewing 3 of 4 board members. Get the full list »

Intensity Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Intensity Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Intensity Therapeutics‘s full profile, request access.

Request a free trial